Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Cubist Pharmaceuticals Inc (CBST)    
$63.93 0.74 (1.17%) as of 4:30 Wed 4/16


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 74,060,000 as of 12/25
Market Cap: 4.73(B)
Last Volume: 680,437 Avg Vol: 973,656
52 Week Range: $44.66 - $81.23
Level I Sector: Health Care
Level II Sector:   Drugs
Level III Sector:      Drug Manufacturers - Other

Member Indexes:

    NASDAQ BIOTECHNOLOGY       NASDAQ COMPOSITE  
    NASDAQ NNM COMPOSITE  

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  951
Guru Rank Value     : 0.1
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
 

Company Profile   Cubist Pharmaceuticals is a biopharmaceutical company focused on the research, development and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment. Co. has three marketed products: CUBICIN® (daptomycin for injection), a once-daily, bactericidal, intravenous antibiotic with activity against certain Gram-positive organisms; ENTEREG (alvimopan), an oral, peripherally-acting mu opioid receptor antagonist approved to accelerate upper and lower gastrointestinal recovery following partial large or small bowel resection surgery with primary anastomosis; and DIFICID (fidaxomicin) for the treatment of clostridium difficile-associated diarrhea.

 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 171,940 332,564 572,341 919,133
Total Sell Value $13,779,457 $24,946,942 $37,872,390 $53,027,743
Total People Sold 7 7 11 13
Total Sell Transactions 11 20 49 87
End Date 2014-01-16 2013-10-15 2013-04-16 2012-04-16

   
Records found: 615
  Page 1 of 25  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Desrosier Thomas EVP, Chief Legaland Administra   •       •      –    2014-04-16 4 AS $64.00 $49,152 D/D (768) 1,609     -
   Tomsicek Michael John SVP & Chief Financial Officer   •       •      –    2014-04-16 4 AS $64.00 $28,224 D/D (441) 4,290     -
   Desrosier Thomas EVP, Chief Legaland Administra   •       •      –    2014-04-15 4 OE $0.00 $0 D/D 2,377 2,377     -
   Tomsicek Michael John SVP & Chief Financial Officer   •       •      –    2014-04-15 4 OE $0.00 $0 D/D 1,361 4,731     -
   Bonney Michael W Chief Executive Officer   •       •      –    2014-03-31 4 A $73.15 $15,581 I/I 213 6,816     -
   Perez Robert J President & COO   •       •      –    2014-03-31 4 A $73.15 $15,581 I/I 213 5,012     -
   Tomsicek Michael John SVP & Chief Financial Officer   •       •      –    2014-03-31 4 A $73.15 $5,633 I/I 77 1,054     -
   Stea Gregory SVP, Commercial Operations   •       •      –    2014-03-31 4 A $73.15 $7,315 I/I 100 434     -
   Desrosier Thomas EVP, Chief Legaland Administra   •       •      –    2014-03-31 4 A $73.15 $6,145 I/I 84 342     -
   Gilman Steven C EVP & Chief Scientific Officer   •       •      –    2014-03-31 4 A $73.15 $8,120 I/I 111 2,744     -
   Stea Gregory SVP, Commercial Operations   •       •      –    2014-03-06 4 AS $79.99 $367,954 D/D (4,600) 16,276 -18%     
   Stea Gregory SVP, Commercial Operations   •       •      –    2014-03-06 4 OE $42.09 $193,614 D/D 4,600 20,876     -
   Stea Gregory SVP, Commercial Operations   •       •      –    2014-03-05 4 AS $79.57 $1,218,039 D/D (15,289) 16,276 -21%     
   Stea Gregory SVP, Commercial Operations   •       •      –    2014-03-05 4 OE $21.56 $561,928 D/D 15,289 19,176     -
   Corrigan Mark Director   •       •      –    2014-02-27 4 AS $80.00 $400,000 D/D (5,000) 5,498 -22%     
   Bonney Michael W Chief Executive Officer   •       •      –    2014-02-27 4 OE $10.84 $1,084,000 D/D 100,000 268,485     -
   Bonney Michael W Chief Executive Officer   •       •      –    2014-02-27 4 AS $81.25 $8,125,130 D/D (100,000) 168,485 -22%     
   Perez Robert J President & COO   •       •      –    2014-02-27 4 OE $19.51 $585,300 D/D 30,000 71,662     -
   Perez Robert J President & COO   •       •      –    2014-02-27 4 AS $80.18 $2,405,439 D/D (30,000) 41,662 -22%     
   Corrigan Mark Director   •       •      –    2014-02-27 4 OE $18.22 $91,100 D/D 5,000 10,498     -
   Bonney Michael W Chief Executive Officer   •       •      –    2014-02-20 4 AS $75.60 $235,268 D/D (3,112) 168,485 -19%     
   Bonney Michael W Chief Executive Officer   •       •      –    2014-02-19 4 OE $0.00 $0 D/D 9,500 171,597     -
   Perez Robert J President & COO   •       •      –    2014-02-18 4 AS $75.00 $262,800 D/D (3,504) 41,662 -19%     
   Gilman Steven C EVP & Chief Scientific Officer   •       •      –    2014-02-18 4 AS $75.00 $198,375 D/D (2,645) 24,493 -19%     
   Tomsicek Michael John SVP & Chief Financial Officer   •       •      –    2014-02-18 4 AS $75.00 $41,625 D/D (555) 3,370 -19%     

  615 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 25
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed